These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 16938861)

  • 21. Control of nerve agent-induced seizures is critical for neuroprotection and survival.
    Shih TM; Duniho SM; McDonough JH
    Toxicol Appl Pharmacol; 2003 Apr; 188(2):69-80. PubMed ID: 12691725
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unequal efficacy of pyridinium oximes in acute organophosphate poisoning.
    Antonijevic B; Stojiljkovic MP
    Clin Med Res; 2007 Mar; 5(1):71-82. PubMed ID: 17456837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pyridinium, imidazolium and quinuclidinium compounds: toxicity and antidotal effects against the nerve agents Tabun and Soman.
    Reiner E; Simeon-Rudolf V
    Arh Hig Rada Toksikol; 2006 Jun; 57(2):171-9. PubMed ID: 16832972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reactivation kinetics of acetylcholinesterase from different species inhibited by highly toxic organophosphates.
    Worek F; Reiter G; Eyer P; Szinicz L
    Arch Toxicol; 2002 Sep; 76(9):523-9. PubMed ID: 12242610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between reversible acetylcholinesterase inhibition and efficacy against soman lethality.
    Lennox WJ; Harris LW; Talbot BG; Anderson DR
    Life Sci; 1985 Sep; 37(9):793-8. PubMed ID: 4033355
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of several oximes against poisoning by soman, tabun and GF.
    Lundy PM; Hansen AS; Hand BT; Boulet CA
    Toxicology; 1992; 72(1):99-105. PubMed ID: 1539175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro reactivation potency of some acetylcholinesterase reactivators against sarin- and cyclosarin-induced inhibitions.
    Kuca K; Cabal J; Jun D; Kassa J; Bartosová L; Kunesová G
    J Appl Toxicol; 2005; 25(4):296-300. PubMed ID: 16025528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reactivators of acetylcholinesterase inhibited by organophosphorus nerve agents.
    Mercey G; Verdelet T; Renou J; Kliachyna M; Baati R; Nachon F; Jean L; Renard PY
    Acc Chem Res; 2012 May; 45(5):756-66. PubMed ID: 22360473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of excitotoxicity in organophosphorous nerve agents central poisoning.
    Solberg Y; Belkin M
    Trends Pharmacol Sci; 1997 Jun; 18(6):183-5. PubMed ID: 9226993
    [No Abstract]   [Full Text] [Related]  

  • 30. Non-enzymatic pretreatment of nerve agent (soman) poisoning: a brief state-of-the-art review.
    van Helden HP; Joosen MJ; Philippens IH
    Toxicol Lett; 2011 Sep; 206(1):35-40. PubMed ID: 21554933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histopathologic changes in the brain, heart, and skeletal muscle of rhesus macaques, ten days after exposure to soman (an organophosphorus nerve agent).
    Britt JO; Martin JL; Okerberg CV; Dick EJ
    Comp Med; 2000 Apr; 50(2):133-9. PubMed ID: 10857003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the efficacy of two carbamates, physostigmine and pyridostigmine, when used in conjunction for protection against organophosphate exposure.
    Solana RP; Gennings C; Carter WH; Anderson D; Lennox WJ; Carchman RA; Harris LW
    Fundam Appl Toxicol; 1990 Nov; 15(4):814-9. PubMed ID: 2086320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minimum effective drug concentrations of a transdermal patch system containing procyclidine and physostigmine for prophylaxis against soman poisoning in rhesus monkeys.
    Cho Y; Kim WS; Hur GH; Ha YC
    Environ Toxicol Pharmacol; 2012 Jan; 33(1):1-8. PubMed ID: 22051905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular consequences of organophosphorus poisoning and of antidotes in conscious unrestrained rats.
    Bataillard A; Sannajust F; Yoccoz D; Blanchet G; Sentenac-Roumanou H; Sassard J
    Pharmacol Toxicol; 1990 Jul; 67(1):27-35. PubMed ID: 2395813
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Degradation of nerve agents by an organophosphate-degrading agent (OpdA).
    Dawson RM; Pantelidis S; Rose HR; Kotsonis SE
    J Hazard Mater; 2008 Sep; 157(2-3):308-14. PubMed ID: 18258361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating the broad-spectrum efficacy of the acetylcholinesterase oximes reactivators MMB4 DMS, HLö-7 DMS, and 2-PAM Cl against phorate oxon, sarin, and VX in the Hartley guinea pig.
    Wilhelm CM; Snider TH; Babin MC; Platoff GE; Jett DA; Yeung DT
    Neurotoxicology; 2018 Sep; 68():142-148. PubMed ID: 30056178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of the effect of selected cholinesterase reactivators combined with atropine on soman and fosdrin toxicity in mice].
    Kassa J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1995; 38(1):63-6. PubMed ID: 9441373
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of pharmacologic prophylaxis with Panpal on acetylcholinesterase activity in the diaphragm and various parts of the brain in rats during treated and untreated Soman poisoning].
    Kassa J
    Cas Lek Cesk; 1998 May; 137(10):299-302. PubMed ID: 9650360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Perspectives in the treatments of poisonings by organophosphorus insecticides and warfare nerve agents].
    Sogorb-Sánchez MA; Vilanova-Gisbert E; Carrera-González V
    Rev Neurol; 2004 Oct 16-31; 39(8):739-47. PubMed ID: 15514903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nerve agents: implications for anesthesia providers.
    Hrobak PK
    AANA J; 2008 Apr; 76(2):95-7. PubMed ID: 18478812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.